MedPath

Dexmedetomidine versus Dexamethasone as an adjuvant to 0.25% Ropivacaine in Ultrasound guided bilateral Rectus Sheath.

Phase 1
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/01/062115
Lead Sponsor
Himalayan Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients aged between 18-60 years.

Physical status ASA I and ASA II

Undergoing elective midline abdominal laparotomy under General

Anesthesia

Exclusion Criteria

Patients aged less than 18 years or more than 60 years

Physical status ASA III and ASA IV

Allergic to any medication to be used in this study

Bleeding diathesis

Active skin infection over the area Of injection

Patients who shall not give consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath